These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9221667)

  • 1. [The isolation of the surface antigen from vegetative cells of Bacillus anthracis STI-1 and study of its protective properties].
    Beznosov MV; Petrov GA; Sorkin IuI; Filippova OL; Rogov SN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):9-13. PubMed ID: 9221667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The isolation and purification of the protective antigen and the edema factor from the culture filtrate of Bacillus anthracis STI-1].
    Rogov SN; Beznosov MV; Chugaĭ VL; Bashkova VA
    Med Parazitol (Mosk); 1995; (4):35-8. PubMed ID: 8587516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the protective antigen of Bacillus anthracis on the formation of immunity under the action of live anthrax vaccines].
    Abalakin VA; Buravtseva NP; Cherkasskiĭ BL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):72-5. PubMed ID: 2117320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.
    Uchida M; Harada T; Enkhtuya J; Kusumoto A; Kobayashi Y; Chiba S; Shyaka A; Kawamoto K
    Biochem Biophys Res Commun; 2012 May; 421(2):323-8. PubMed ID: 22507985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation and study of an anthrax protective antigen. V. The dynamics of immunity in vaccination with a concentrated, purified sorbed chemical anthrax vaccine].
    Sadoyoĭ NV; Derbin MI; Garin NS; Tarumov VS; Mikhaĭlov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):64-7. PubMed ID: 110017
    [No Abstract]   [Full Text] [Related]  

  • 7. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
    Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changing the protective properties of the receptor domain of protective antigen anthrax exotoxin, depending on the orientation of the presentation on nanoparticles].
    Noskov KA; Shcheglovitova ON; Skliarov OD; Noskov AN
    Bioorg Khim; 2011; 37(4):504-9. PubMed ID: 22096993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extraction and study of anthrax protective antigen. III. Improvement in the method of obtaining chemical anthrax vaccine under laboratory conditions].
    Debrin MI; Kuz'mich MK; Garin NS; Tarumov VS; Mikhaĭlov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):63-7. PubMed ID: 404807
    [No Abstract]   [Full Text] [Related]  

  • 11. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.
    Wui SR; Kim HK; Han JE; Kim JM; Kim YH; Chun JH; Cho YJ; Lee NG
    Int Immunopharmacol; 2011 Sep; 11(9):1195-204. PubMed ID: 21492746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a newly discovered antigen of Bacillus cereus biovar anthracis for its suitability in specific serological antibody testing.
    Dupke S; Barduhn A; Franz T; Leendertz FH; Couacy-Hymann E; Grunow R; Klee SR
    J Appl Microbiol; 2019 Jan; 126(1):311-323. PubMed ID: 30253024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
    Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunogenicity and heterogeneity of Pseudomonas pseudomallei surface antigen 8].
    Piven' NN; Smirnova VI; Viktorov DV; Kovalenko AA; Farber SM; Iarulin RG; Podzolkova GG
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):75-8. PubMed ID: 9027183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectives.
    Adamo R
    Expert Rev Vaccines; 2014 Jul; 13(7):895-907. PubMed ID: 24867680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of isogenic variants of Bacillus anthracis with various content of virulence plasmids].
    Barkova IA; Novozhenina AV; Barkov AM; Porokhnia SV; Tkachenko GA; Lipnitskiĭ AV
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):17-22. PubMed ID: 25842948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen delivery by attenuated Bacillus anthracis: new prospects in veterinary vaccines.
    Brossier F; Mock M; Sirard JC
    J Appl Microbiol; 1999 Aug; 87(2):298-302. PubMed ID: 10475973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.